Restoration of Mitochondrial Homeostasis in Post-Ovulatory Ageing
Oocytes Through Elamipretide–Mediated Modulation of SIRT3, Redox
Balance, and Bioenergetics
Alicja Kowalczyk1*, Mercedes Camiña García2,
José Ángel Hernández Malagón 3, Jose Pedro Araujo4,
Wojciech Witkiewicz5, Joanna Gruszczyńska6,
Marko Samardžija7 Marcjanna Wrzecińska1,
Elżbieta Gałęska1, Ewa Czerniawska-Piątkowska8
and Zbigniew Dobrzański1
1Department
of Environment Hygiene and Animal Welfare, Wrocław University of
Environmental and Life Sciences, Wrocław, Poland; 2Department
of Physiology, Faculty of Veterinary, University of Santiago de
Compostela, 27002 Lugo, Spain; 3COPAR (GI-2120) Research
Group, Department of Animal Pathology, Faculty of Veterinary, Campus
Terra, University of Santiago de Compostela, 27002, Lugo, Spain;
4Escola Superior Agrária, Inst. Polit. de Viana do
Castelo, Refóios do Lima, 4990-706 Ponte de Lima, Portugal; 5Research
and Development Center, Voivodeship Specialist Hospital in Wrocław,
51-124 Wrocław, Poland; 6Department of Animal Genetic and
Conservation, Warsaw University of Life Sciences, Institute of
Animal Sciences, Warsaw, Poland; 7Clinic for Reproduction
and Obstetrics, Veterinary Faculty, University of Zagreb, Heinzelova
55, 10000 Zagreb, Croatia; 8Department of Ruminant
Science, West Pomeranian University of Technology in Szczecin,
Poland
The study investigated whether the mitochondrial-targeted antioxidant peptide
SS-31 (elamipretide) can mitigate post-ovulatory ageing-related mitochondrial
dysfunction in bovine oocytes by modulating SIRT3 expression, oxidative stress,
ATP content and mitochondrial membrane potential during in vitro maturation.
Cumulus–oocyte complexes were collected from bovine ovaries and matured for 12,
36, or 52 hours and treated with SS-31 at 0.3, 0.6, or 0.9 µM, or cultured
without antioxidants. SIRT3 expression was quantified by immunofluorescence,
reactive oxygen species levels were measured using fluorescent probes, ATP
content was evaluated using bioluminescence assays, and mitochondrial membrane
potential was evaluated using JC-1 staining. Data were analyzed using two-way
analysis of variance (ANOVA) with post hoc testing. SS-31 led to a
dose-dependent increase in SIRT3 expression at all time points. ROS levels
increased with duration of incubation; however, SS-31 treatment notably reduced
oxidative stress, particularly at early and mid stage incubation. The ATP
content increased over time, but remained lower in oocytes treated with SS-31,
which may reflect alterations in mitochondrial metabolism; however, this
requires further investigation. Mitochondrial membrane potential was enhanced by
SS-31, with the strongest improvement observed at 0.6 µM after 12 and 36 hours.
SS-31 appears to alleviate age-associated mitochondrial deterioration by
improving SIRT3 expression, reducing ROS accumulation, and stabilizing
mitochondrial membrane potential. In this context, SS-31 appears to support
oocyte bioenergetic quality and may represent a promising approach as a tool for
improving reproductive outcomes, particularly in cases of age-related fertility
decline.
To Cite This Article:
Kowalczyk A, García MC, Malagón JAH, Araujo JP, Witkiewicz W, Gruszczyńska J,
Samardžija M, Wrzecińska M, Gałęska E, Czerniawska-Piątkowska E and Dobrzański
Z, 2026. Restoration of mitochondrial homeostasis in post-ovulatory ageing
oocytes through elamipretide–mediated modulation of SIRT3, redox balance, and
bioenergetics. Pak Vet J, 46(5): 1209-1218.
http://dx.doi.org/10.29261/pakvetj/2026.108